RevelAi Health, a conversational AI platform for musculoskeletal care, has closed a $3.1M seed round led by Ulu Ventures and Symphonic Capital.
The platform provides a 24/7 virtual care navigator automating critical workflows in musculoskeletal care to align with value-based care models.
The U.S. is facing a projected shortage of physicians for musculoskeletal care, and CMS is transitioning hospitals to risk-based payment models.
RevelAi Health aims to enhance efficiency and quality outcomes for orthopedic practices facing these challenges.
The platform acts as a virtual care navigator automating manual tasks such as triage, quality reporting, and clinical documentation.
It automates episode-wide workflows without additional staff clicks, ensuring guideline-concordant recommendations for value-based musculoskeletal care.
The seed funding will be used to integrate with EHRs, enhance outcome surveys, and expand engineering and research teams.
Expansion plans include refining clinical content and decision logic with input from orthopedic surgeons.
Christian Pean, MD, Founder & CEO of RevelAi Health, highlights the platform's role in supporting the shift towards population-level accountability in musculoskeletal care.